ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息（分红）
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Silexion Therapeutics Corp
1.42
-0.1400
-8.97%
盤後：
1.42
0.0000
0.00%
16:10 EST
成交量：
3.67萬
成交額：
5.49萬
市值：
443.98萬
市盈率：
-0.06
高：
1.60
開：
1.54
低：
1.42
收：
1.56
52周最高：
26.70
52周最低：
1.42
股本：
312.66萬
流通股本：
275.35萬
量比：
1.73
換手率：
1.33%
股息：
- -
股息率：
- -
每股收益(TTM):
-25.2122
每股收益(LYR):
-395.3595
淨資產收益率：
-771.23%
總資產收益率：
-77.60%
市淨率：
0.64
市盈率(LYR):
0.00
資料載入中...
總覽
公司
新聞資訊
公告
公司資料
公司名字：
Silexion Therapeutics Corp
交易所：
NASDAQ
成立時間：
2008
員工人數：
13
公司地址：
The Goldyne Savad Inst. of Gene Therapy,Hadassah Hebrew Univ Medical Ctr,Jerusalem,Israel
官網：
http://www.silexion.com
郵編：
9112001
電話：
972 2 674 3430
傳真：
972 2 643 0982
簡介：
Silexion Therapeutics Corp是一家開曼群島豁免公司。Silexion Therapeutics Ltd.是Biomotion Sciences的子公司。Silexion Therapeutics Ltd.是一家臨床階段、專註於腫瘤學的生物技術公司，致力於發現和開發KRAS驅動的癌症的專有療法。Silexion的主要候選產品SIL-204B由局部給藥的小干擾RNA或siRNA組成，採用緩釋製劑，作為局部晚期胰腺癌患者的一線治療，與標準護理化療相結合。SIL-204B是繼Silexion的第一代siRNA候選產品SIG12D-LODER（也稱為Loder）的1期和2期臨床試驗之後的第二代siRNA候選產品。儘管未確定最大耐受劑量，但1期臨床試驗同時達到了主要和次要終點。在2期臨床試驗中，雖然沒有達到所有患者的主要終點，但結果显示KRAS G12D/V突變患者的治療組之間存在差異趨勢，Loder組的總體生存期優勢為9.3個月。關於2期臨床試驗中的次要安全性終點，達到了終點。對於次要療效終點，未觀察到統計學上的顯著差異，也沒有足夠的數據進行評估。由於1期和2期試驗的規模較小，它們沒有提供統計學意義。
董事
名稱
職位
Ilan Hadar
Chairman and Chief Executive Officer
Amnon Peled
Director
Avner Lushi
Director
Dror J. Abramov
Director
Ilan Levin
Director
Ruth Alon
Director
Shlomo Noy
Director
股東
名稱
職位
Ilan Hadar
Chairman and Chief Executive Officer
Mirit Horenshtein Hadar
Chief Financial Officer and Secretary
Mitchell Shirvan
Chief Scientific and Development Officer
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/SLXN/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SLXN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SLXN\",,,,,undefined,":{"symbol":"SLXN","market":"US","secType":"STK","nameCN":"Silexion Therapeutics Corp","latestPrice":1.42,"timestamp":1771880400000,"preClose":1.56,"halted":0,"volume":36670,"hourTrading":{"tag":"盘后","latestPrice":1.42,"preClose":1.42,"latestTime":"16:10 EST","volume":273,"amount":388.0200051,"timestamp":1771881004771,"change":0,"changeRate":0,"amplitude":0.028169},"delay":0,"changeRate":-0.08974358974358981,"floatShares":2753490,"shares":3126642,"eps":-25.2122,"marketStatus":"盤後交易","change":-0.14,"latestTime":"02-23 17:09:37 EST","open":1.54,"high":1.5988,"low":1.42,"amount":54939.759732,"amplitude":0.114615,"askPrice":1.67,"askSize":200,"bidPrice":1.3,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-25.2122,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1771894800000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":1.56,"preHourTrading":{"tag":"盘前","latestPrice":1.56,"preClose":1.56,"latestTime":"08:52 EST","volume":1915,"amount":2986.519866,"timestamp":1771854751103,"change":0,"changeRate":0,"amplitude":0.070513},"postHourTrading":{"tag":"盘后","latestPrice":1.42,"preClose":1.42,"latestTime":"16:10 EST","volume":273,"amount":388.0200051,"timestamp":1771881004771,"change":0,"changeRate":0,"amplitude":0.028169},"volumeRatio":1.732135},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SLXN\",,,,,undefined,":{"symbol":"SLXN","floatShares":2753490,"roa":"-77.60%","roe":"-771.23%","lyrEps":-395.359461,"volumeRatio":1.732135,"shares":3126642,"dividePrice":0,"high":1.5988,"amplitude":0.114615,"preClose":1.56,"low":1.42,"week52Low":1.42,"pbRate":"0.64","week52High":26.7,"institutionHeld":0,"latestPrice":1.42,"committee":-0.99005,"eps":-25.2122,"divideRate":0,"volume":36670,"delay":0,"ttmEps":-25.2122,"open":1.54,"prevYearClose":1.92,"prevWeekClose":1.56,"prevMonthClose":1.83,"prevQuarterClose":1.92,"fiveDayClose":1.59,"twentyDayClose":2.17,"sixtyDayClose":2.23},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SLXN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-07-29","symbol":"SLXN","defaultRemindTime":1753795800000,"type":"split","dateTimestamp":1753761600000,"forFactor":15,"toFactor":1,"ratio":15},{"market":"US","date":"2024-11-29","symbol":"SLXN","defaultRemindTime":1732890600000,"type":"split","dateTimestamp":1732856400000,"forFactor":9,"toFactor":1,"ratio":9},{"market":"US","date":"2024-08-13","symbol":"SLXN","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SLXN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SLXN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1765861200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SLXN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SLXN","date":"2026-02-20","current":-0.059931,"percent":0.234146,"low":-1.070842,"twenty":-0.591719,"median":-0.41963,"eighty":-0.125548,"high":-0.075397,"avg":-0.405996,"sd":0.24995,"marketCap":4940094},"quantilePoints":[{"date":"2025-05-02","current":-0.511745,"twenty":-0.505522,"median":-0.478123,"eighty":-0.462658,"marketCap":8414615},{"date":"2025-05-09","current":-0.508623,"twenty":-0.511745,"median":-0.504017,"eighty":-0.475134,"marketCap":8363285},{"date":"2025-05-16","current":-0.49368,"twenty":-0.511295,"median":-0.503966,"eighty":-0.488849,"marketCap":8117579},{"date":"2025-05-23","current":-0.504427,"twenty":-0.509135,"median":-0.49826,"eighty":-0.470682,"marketCap":8294286},{"date":"2025-05-30","current":-0.491275,"twenty":-0.511407,"median":-0.49826,"eighty":-0.475032,"marketCap":8078030},{"date":"2025-06-06","current":-0.471573,"twenty":-0.511407,"median":-0.49368,"eighty":-0.475196,"marketCap":7754067},{"date":"2025-06-13","current":-0.453201,"twenty":-0.509647,"median":-0.491403,"eighty":-0.471409,"marketCap":7451983},{"date":"2025-06-20","current":-0.41963,"twenty":-0.506945,"median":-0.488844,"eighty":-0.464552,"marketCap":6899984},{"date":"2025-06-27","current":-0.415025,"twenty":-0.504283,"median":-0.484008,"eighty":-0.449824,"marketCap":6824252},{"date":"2025-07-03","current":-0.415025,"twenty":-0.504048,"median":-0.478123,"eighty":-0.41963,"marketCap":6824252},{"date":"2025-07-11","current":-0.42265,"twenty":-0.503966,"median":-0.474592,"eighty":-0.417174,"marketCap":6949630},{"date":"2025-07-18","current":-0.440049,"twenty":-0.503178,"median":-0.468758,"eighty":-0.415025,"marketCap":7235727},{"date":"2025-07-25","current":-0.430889,"twenty":-0.49932,"median":-0.464408,"eighty":-0.415332,"marketCap":7085105},{"date":"2025-08-01","current":-0.509697,"twenty":-0.49932,"median":-0.462719,"eighty":-0.415332,"marketCap":8380951},{"date":"2025-08-08","current":-0.292718,"twenty":-0.495931,"median":-0.452101,"eighty":-0.414513,"marketCap":4813156},{"date":"2025-08-15","current":-0.251096,"twenty":-0.493608,"median":-0.447572,"eighty":-0.409037,"marketCap":4128768},{"date":"2025-08-22","current":-0.231991,"twenty":-0.492964,"median":-0.436237,"eighty":-0.386752,"marketCap":3814623},{"date":"2025-08-29","current":-0.263889,"twenty":-0.49148,"median":-0.430786,"eighty":-0.303498,"marketCap":4339133},{"date":"2025-09-05","current":-0.238814,"twenty":-0.491275,"median":-0.423383,"eighty":-0.280777,"marketCap":3926818},{"date":"2025-09-12","current":-0.168193,"twenty":-0.491275,"median":-0.420859,"eighty":-0.25246,"marketCap":2765601},{"date":"2025-09-19","current":-0.12316,"twenty":-0.486413,"median":-0.417583,"eighty":-0.247343,"marketCap":2025116},{"date":"2025-09-26","current":-0.128618,"twenty":-0.486106,"median":-0.415793,"eighty":-0.244955,"marketCap":2114871},{"date":"2025-10-03","current":-0.128618,"twenty":-0.484008,"median":-0.415025,"eighty":-0.242737,"marketCap":2114871},{"date":"2025-10-10","current":-0.136465,"twenty":-0.48104,"median":-0.413413,"eighty":-0.231991,"marketCap":2243896},{"date":"2025-10-17","current":-0.121454,"twenty":-0.478123,"median":-0.409651,"eighty":-0.138853,"marketCap":1997067},{"date":"2025-10-24","current":-0.114972,"twenty":-0.478123,"median":-0.401489,"eighty":-0.132201,"marketCap":1890482},{"date":"2025-10-31","current":-0.112584,"twenty":-0.477611,"median":-0.386196,"eighty":-0.129301,"marketCap":1851214},{"date":"2025-11-07","current":-0.097914,"twenty":-0.471573,"median":-0.312505,"eighty":-0.127936,"marketCap":1609995},{"date":"2025-11-14","current":-0.097914,"twenty":-0.471163,"median":-0.292718,"eighty":-0.123842,"marketCap":1609995},{"date":"2025-11-21","current":-0.080173,"twenty":-0.468758,"median":-0.272333,"eighty":-0.121795,"marketCap":1318288},{"date":"2025-11-28","current":-0.096549,"twenty":-0.467039,"median":-0.257237,"eighty":-0.120362,"marketCap":1587556},{"date":"2025-12-05","current":-1.070842,"twenty":-0.471245,"median":-0.259284,"eighty":-0.119953,"marketCap":9902075},{"date":"2025-12-12","current":-1.0279,"twenty":-0.478706,"median":-0.282158,"eighty":-0.120362,"marketCap":9504991},{"date":"2025-12-19","current":-0.821644,"twenty":-0.486167,"median":-0.30227,"eighty":-0.120704,"marketCap":7597740},{"date":"2025-12-26","current":-0.797975,"twenty":-0.491377,"median":-0.316599,"eighty":-0.121181,"marketCap":7378875},{"date":"2026-01-02","current":-0.6492,"twenty":-0.495368,"median":-0.386196,"eighty":-0.12159,"marketCap":6003152},{"date":"2026-01-09","current":-0.710063,"twenty":-0.504027,"median":-0.401489,"eighty":-0.122205,"marketCap":6565948},{"date":"2026-01-16","current":-0.825025,"twenty":-0.510588,"median":-0.409651,"eighty":-0.122955,"marketCap":7629006},{"date":"2026-01-23","current":-0.726969,"twenty":-0.515839,"median":-0.412313,"eighty":-0.12316,"marketCap":6722280},{"date":"2026-01-30","current":-0.662725,"twenty":-0.574408,"median":-0.414769,"eighty":-0.123296,"marketCap":6128218},{"date":"2026-02-06","current":-0.510569,"twenty":-0.606596,"median":-0.415025,"eighty":-0.12391,"marketCap":4721229},{"date":"2026-02-13","current":-0.534237,"twenty":-0.597129,"median":-0.417327,"eighty":-0.124456,"marketCap":4940094},{"date":"2026-02-20","current":-0.534237,"twenty":-0.591719,"median":-0.41963,"eighty":-0.125548,"marketCap":4940094}],"updateTime":1771861920716},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":134350646,"yearFounded":2008,"employeeNum":13,"address":"The Goldyne Savad Inst. of Gene Therapy,Hadassah Hebrew Univ Medical Ctr,Jerusalem,Israel","zipCode":"9112001","officePhone":"972 2 674 3430","officeFax":"972 2 643 0982"},"stockCompanyDetail":{"websiteUrl":"http://www.silexion.com","stockEarnings":[{"period":"1week","weight":-0.0189},{"period":"1month","weight":-0.2607},{"period":"3month","weight":-0.2941},{"period":"6month","weight":-0.7827},{"period":"1year","weight":-0.8831},{"period":"ytd","weight":-0.1875}],"compareEarnings":[{"period":"1week","weight":0.0113},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0461},{"period":"6month","weight":0.0684},{"period":"1year","weight":0.1295},{"period":"ytd","weight":0.011}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Silexion Therapeutics Corp是一家開曼群島豁免公司。Silexion Therapeutics Ltd.是Biomotion Sciences的子公司。Silexion Therapeutics Ltd.是一家臨床階段、專註於腫瘤學的生物技術公司，致力於發現和開發KRAS驅動的癌症的專有療法。Silexion的主要候選產品SIL-204B由局部給藥的小干擾RNA或siRNA組成，採用緩釋製劑，作為局部晚期胰腺癌患者的一線治療，與標準護理化療相結合。SIL-204B是繼Silexion的第一代siRNA候選產品SIG12D-LODER（也稱為Loder）的1期和2期臨床試驗之後的第二代siRNA候選產品。儘管未確定最大耐受劑量，但1期臨床試驗同時達到了主要和次要終點。在2期臨床試驗中，雖然沒有達到所有患者的主要終點，但結果显示KRAS G12D/V突變患者的治療組之間存在差異趨勢，Loder組的總體生存期優勢為9.3個月。關於2期臨床試驗中的次要安全性終點，達到了終點。對於次要療效終點，未觀察到統計學上的顯著差異，也沒有足夠的數據進行評估。由於1期和2期試驗的規模較小，它們沒有提供統計學意義。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.016335},{"month":2,"riseRate":0.6,"avgChangeRate":-0.113254},{"month":3,"riseRate":1,"avgChangeRate":0.013692},{"month":4,"riseRate":0.75,"avgChangeRate":-0.019534},{"month":5,"riseRate":0.4,"avgChangeRate":0.010327},{"month":6,"riseRate":0.4,"avgChangeRate":-0.035519},{"month":7,"riseRate":1,"avgChangeRate":0.055675},{"month":8,"riseRate":0.4,"avgChangeRate":-0.277749},{"month":9,"riseRate":0.6,"avgChangeRate":-0.230878},{"month":10,"riseRate":0.4,"avgChangeRate":-0.091257},{"month":11,"riseRate":0.4,"avgChangeRate":-0.018649},{"month":12,"riseRate":0.2,"avgChangeRate":-0.12005}],"exchange":"NASDAQ","name":"Silexion Therapeutics Corp","nameEN":"Silexion Therapeutics Corp"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"SLXN\",market:\"US\",,,undefined,":{"directors":[{"name":"Ilan Hadar","position":"Chairman and Chief Executive Officer"},{"name":"Amnon Peled","position":"Director"},{"name":"Avner Lushi","position":"Director"},{"name":"Dror J. Abramov","position":"Director"},{"name":"Ilan Levin","position":"Director"},{"name":"Ruth Alon","position":"Director"},{"name":"Shlomo Noy","position":"Director"}],"executives":[{"name":"Ilan Hadar","position":"Chairman and Chief Executive Officer"},{"name":"Mirit Horenshtein Hadar","position":"Chief Financial Officer and Secretary"},{"name":"Mitchell Shirvan","position":"Chief Scientific and Development Officer"}]}}}